47.9
過往表現並非未來業績的可靠指標. 所示股價僅供參考，可能與實時市價存在差異。
交易 uniQure N.V. - QURE 差價合約
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington''s disease; AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer''s disease; and AMT-210 that is in preclinical trial to treat Parkinson''s disease. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.最新股票文章
期貨是什麼？一文看懂期貨合約運作、種類與香港交易入門
期貨是什麼？本文拆解期貨合約組成、保證金計算與常見類型（股指、商品、加密貨幣），並詳解香港恒指期貨玩法、開戶流程及風險管理，新手必讀入門教學。
10:57, 16 6月 2026
ETF是什麼？一文讀懂交易所買賣基金的運作、種類與投資方法
ETF是什麼？本文深入解析交易所買賣基金的運作原理、主要類型（指數、債券、主題、槓桿反向）、投資費用及香港/美股熱門ETF清單，幫助新手快速開始ETF投資。
10:21, 16 6月 2026
港人實戰：如何佈局 SpaceX IPO 前後的交易節奏
SpaceX以750億美元完成歷史性IPO，估值1.77萬億美元。深度解析港股CFD交易策略、供應鏈映射與恒生指數聯動，助投資者理解太空經濟相關市場動態。資本面臨風險。
08:58, 16 6月 2026
SpaceX上市首日收漲19%——IPO後如何交易SpaceX SPCX差價合約
SpaceX（SPCX）於2026年6月12日在納斯達克首次上市，開盤報150美元，收盤報160.95美元，較135美元的IPO發行價上漲19.2%。
08:23, 16 6月 2026
評級和評論
評級和評論
